Ardent Pharmaceutical is categorized under Commercial Medical Research in Durham, NC and active since 2004.
Ardent Pharmaceutical was established in 2004, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Richard S Kent at the company’s single location by writing to 631 United Drive, Durham, North Carolina NC 27713 or by phoning (919) 806-1806. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ardent Pharmaceutical |
| Contact Person: | Richard S Kent |
| Address: | 631 United Drive, Durham, North Carolina 27713 |
| Phone Number: | (919) 806-1806 |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 4242101 |
| Share This Business: |
Ardent Pharmaceutical was started in 2004 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Richard S Kent for inquiries that concern Ardent Pharmaceutical by calling the company number (919) 806-1806, as your correspondence is most welcome. Additionally, the physical location of the single location of Ardent Pharmaceutical can be found at the coordinates 35.93697,-78.902 as well as the street address 631 United Drive in Durham, North Carolina 27713.
For its online presence, you may visit Ardent Pharmaceutical’s website at and engage with its social media outlets through on Twitter and on Facebook.